|
Status |
Public on Feb 26, 2024 |
Title |
Gene regulatory basis of bystander activation in CD8+ T cells (RNA-seq) |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The immune system is stratified into layers of specialized cells with distinct functions. Recently, Lin28b was shown to serve as a master regulator of fetal lymphopoiesis and program the development of more innate-like lymphocytes in early life. However, it is still unclear how Lin28b alters the function of fetal-derived lymphocytes and protects the host against infection. In this report, we examined how Lin28b transcriptionally and epigenetically programs murine CD8+ T cells for innate immune defense and translated our key findings to human CD8+ T cells. We found that Lin28b operates as a gatekeeper, opening the door to a hidden diversity of phenotypes that are unveiled upon stimulation with innate cytokines. In particular, Lin28b promotes a transcriptionally and functionally diverse pool of cells through chromatin remodeling. As a result, neonatal CD8+ T cells are able to deploy a bet-hedging immune strategy and protect the host against a wide range of unrelated pathogens.
|
|
|
Overall design |
Gene expression profiling of gBT-I TCR tg adult, neonatal and Lin28b Tg adult CD8+ T cells treated with IL-2 or IL-12/18 by high-throughput sequencing, in 2 or 6 replicates, using Illumina NextSeq500.
|
|
|
Contributor(s) |
Watson NB, Patel RK, Grimson AW, Rudd BD |
Citation(s) |
38394230 |
|
Submission date |
Jul 23, 2021 |
Last update date |
Feb 26, 2024 |
Contact name |
Andrew Grimson |
Organization name |
Cornell University
|
Department |
Molecular Biology and Genetics
|
Street address |
445 Biotech Bldg
|
City |
Ithaca |
State/province |
NY |
ZIP/Postal code |
14850 |
Country |
USA |
|
|
Platforms (1) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
Samples (20)
|
|
This SubSeries is part of SuperSeries: |
GSE180732 |
Gene regulatory basis of bystander activation in CD8+ T cells |
|
Relations |
BioProject |
PRJNA749293 |
SRA |
SRP329628 |